Enhanced immunogenicity of a human immunodeficiency virus type 1 env DNA vaccine by manipulating N-glycosylation signals - Effects of elimination of the V3 N306 glycan

Author: Bolmstedt A.   Hinkula J.   Rowcliffe E.   Biller M.   Wahren B.   Olofsson S.  

Publisher: Elsevier

ISSN: 0264-410X

Source: Vaccine, Vol.20, Iss.3, 2001-11, pp. : 397-405

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content